These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19176447)
21. Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome. Karlström P; Alehagen U; Boman K; Dahlström U; Eur J Heart Fail; 2011 Oct; 13(10):1096-103. PubMed ID: 21715446 [TBL] [Abstract][Full Text] [Related]
22. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis]. Dahlström U; Alehagen U Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036 [No Abstract] [Full Text] [Related]
23. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
24. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708 [TBL] [Abstract][Full Text] [Related]
25. [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure]. Tabak'ian EA; Zaruba AIu; Rogoza AN; Ataullakhanova DM; Kukharchuk VV Ter Arkh; 2010; 82(8):24-9. PubMed ID: 20873241 [TBL] [Abstract][Full Text] [Related]
27. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure. Gallegos PJ; Maclaughlin EJ; Haase KK Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114 [TBL] [Abstract][Full Text] [Related]
28. Biomarker-guided treatment of heart failure: still waiting for a definitive answer. Troughton RW; Frampton CM; Nicholls MG J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970 [No Abstract] [Full Text] [Related]
29. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? Maisel A J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365 [No Abstract] [Full Text] [Related]
31. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure]. Lindstedt G Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037 [No Abstract] [Full Text] [Related]
32. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075 [TBL] [Abstract][Full Text] [Related]
33. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides. Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755 [TBL] [Abstract][Full Text] [Related]
36. Neprilysin in Heart Failure: From Oblivion to Center Stage. Bayés-Genís A JACC Heart Fail; 2015 Aug; 3(8):637-40. PubMed ID: 26251091 [No Abstract] [Full Text] [Related]
37. Correlation of NT-proBNP, proANP and novel biomarkers: copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF, non-ischemic CHF and arterial hypertension. Vondráková D; Málek F; Ošťádal P; Vránová J; Miroslav P; Schejbalová M; Neužil P Int J Cardiol; 2011 Aug; 150(3):343-4. PubMed ID: 21640398 [No Abstract] [Full Text] [Related]
38. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
39. Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure. Tsutamoto T; Sakai H; Ishikawa C; Fujii M; Tanaka T; Yamamoto T; Takashima H; Ohnishi M; Wada A; Horie M Eur J Heart Fail; 2007; 9(6-7):667-73. PubMed ID: 17360233 [TBL] [Abstract][Full Text] [Related]
40. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]